Senior Vice President, Finance - Controller and Chief Accounting Officer @ (January 2025 - January 2025)
Vice President, Finance and Controller - Kidney Care @ (January 2024 - January 2025)
SVP, Finance (Corporate) and CFO, Specialty Generics @ (January 2023 - January 2024)
Global Corporate Controller and Chief Investor Relations Officer @ (January 2021 - January 2023)
Vice President, Restructuring and Investor Relations @ (January 2020 - January 2021)
Vice President, Finance and Investor Relations Officer @ (January 2018 - January 2020)
Director, Investor Relations @ (January 2016 - January 2018)
Manager, Technical Accounting and External Reporting @ (January 2013 - January 2016)
Assurance Manager @ (January 2006 - January 2013)
Daniel Speciale Education
Gies College of Business - University of Illinois Urbana-Champaign
Master's degree (Accounting)
2006
Gies College of Business - University of Illinois Urbana-Champaign
Bachelor’s Degree (Accounting)
2005
Daniel Speciale Skills
Investor Relations
Private Housing
Stakeholder Engagement
Daniel Speciale Summary
Daniel Speciale, based in St. Louis, MO, US, is currently a Chief Financial Officer at Kindeva Drug Delivery. Daniel Speciale brings experience from previous roles at Vantive, Baxter International Inc. and Mallinckrodt Pharmaceuticals. Daniel Speciale holds a Master's degree in Accounting @ Gies College of Business - University of Illinois Urbana-Champaign. With a robust skill set that includes Investor Relations, Private Housing, Stakeholder Engagement and more. Daniel Speciale has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniel Speciale?
Find contact details for 700 million professionals.